Urgent.News

What's breaking now, across thousands of outlets.

AI

Lilly once again beats expectations as tirzepatide accounts for 64% of revenue

Eli Lilly posted $23 billion in second-quarter revenues, coming in about $3 billion above analysts' estimates. Lilly also once again raised its full-year revenue guidance to between $85 billion and $87 ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in AI

More from Wednesday 5 August →